Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China · Delayed Price · Currency is CNY 65.30
+5.18 (8.62%)
Apr 29, 2026, 3:00 PM CST
SHA:603538 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 116.06 | 106.12 | 66.81 | 11.59 | 338.86 | 142.53 |
Depreciation & Amortization | 135.58 | 135.58 | 133.03 | 118.48 | 101.76 | 98.94 |
Other Amortization | 4.02 | 4.02 | 4.59 | 7.66 | 7.5 | 4.82 |
Loss (Gain) From Sale of Assets | 0.14 | 0.14 | 1.08 | -17.51 | 20.31 | 6.17 |
Asset Writedown & Restructuring Costs | 33.94 | 33.94 | - | - | - | - |
Loss (Gain) From Sale of Investments | -7.32 | -7.32 | -4.84 | 0.57 | -183.39 | -21.11 |
Provision & Write-off of Bad Debts | - | - | 0.76 | 6.12 | -0.7 | 2.66 |
Other Operating Activities | 37.49 | 48.13 | 71.42 | 66.39 | 53.08 | 36.03 |
Change in Accounts Receivable | 20.23 | 20.23 | -91.69 | -98.84 | -213.63 | -50.86 |
Change in Inventory | -120.34 | -120.34 | -185.43 | -49.56 | -182.99 | -124.68 |
Change in Accounts Payable | -93.59 | -93.59 | 67.15 | -51.17 | 351.4 | 134.36 |
Change in Other Net Operating Assets | 21.82 | 21.82 | 24.9 | 24.33 | 24.96 | 12.77 |
Operating Cash Flow | 156.86 | 157.56 | 97.54 | 9.13 | 276.95 | 220.63 |
Operating Cash Flow Growth | 24.02% | 61.54% | 967.95% | -96.70% | 25.53% | -3.26% |
Capital Expenditures | -128.91 | -112.08 | -179.4 | -219.54 | -571.62 | -529.89 |
Sale of Property, Plant & Equipment | 18.39 | 18.43 | 2.17 | 0.18 | 3.38 | 2.13 |
Cash Acquisitions | - | - | - | - | - | -47.1 |
Divestitures | - | - | - | 109.96 | 487.93 | - |
Investment in Securities | 82.32 | -23.64 | 72.99 | -222.74 | 181.48 | -90.25 |
Other Investing Activities | -40.22 | 14.79 | 4.46 | 8.54 | -50.92 | 61.86 |
Investing Cash Flow | -68.41 | -102.5 | -99.79 | -323.61 | 50.26 | -603.25 |
Long-Term Debt Issued | - | 1,085 | 717.52 | 708.32 | 769.02 | 847.8 |
Total Debt Issued | 906.58 | 1,085 | 717.52 | 708.32 | 769.02 | 847.8 |
Long-Term Debt Repaid | - | -955.26 | -709.54 | -620.47 | -753.93 | -793.74 |
Total Debt Repaid | -977.43 | -955.26 | -709.54 | -620.47 | -753.93 | -793.74 |
Net Debt Issued (Repaid) | -70.85 | 130.12 | 7.98 | 87.85 | 15.08 | 54.07 |
Issuance of Common Stock | 25.1 | 25.1 | 35.58 | 2.75 | 4.46 | 27.87 |
Repurchase of Common Stock | - | - | -0.63 | -1.12 | -0.1 | -0.17 |
Common Dividends Paid | -26.53 | -25.89 | -22.71 | -59.24 | -50.03 | -13.83 |
Other Financing Activities | -27.3 | -27.6 | 12.16 | 24.63 | -147.87 | 515.22 |
Financing Cash Flow | -99.58 | 101.72 | 32.39 | 54.87 | -178.46 | 583.15 |
Foreign Exchange Rate Adjustments | -1.79 | 6.35 | 8.84 | -3.45 | 14.63 | -2.29 |
Net Cash Flow | -12.91 | 163.14 | 38.98 | -263.06 | 163.39 | 198.23 |
Free Cash Flow | 27.96 | 45.48 | -81.87 | -210.41 | -294.67 | -309.26 |
Free Cash Flow Margin | 1.79% | 3.03% | -5.96% | -17.30% | -20.22% | -24.58% |
Free Cash Flow Per Share | 0.13 | 0.21 | -0.38 | -0.91 | -1.30 | -1.45 |
Cash Income Tax Paid | - | -39.36 | -8.63 | 55 | 35.09 | -48.68 |
Levered Free Cash Flow | -159.39 | -118.86 | -124.44 | -254.43 | -78.85 | -296.94 |
Unlevered Free Cash Flow | -159.39 | -118.86 | -94.27 | -236.27 | -61.69 | -280.02 |
Change in Working Capital | -163.05 | -163.05 | -175.31 | -184.16 | -60.48 | -49.41 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.